Increasing studies have reported that BBR exhibits an inhibitory effect on NLRP3 inflammasome and is a potential candidate for the treatment of various diseases such as atherosclerosis (Jiang et al., 2017), gouty arthritis (Dinesh and Rasool, 2017), and liver injury (Vivoli et al., 2016). The gene discussed is NLRP3; the disease is gout.